Applied Biosciences Corp.

Equities

APPB

US03815L1026

Biotechnology & Medical Research

Market Closed - OTC Markets Other stock markets 14:30:19 23/10/2023 BST			5-day change	1st Jan Change
0.0002 ^USD	-.--%		-.--%	-.--%

2020	Applied BioSciences Corp. Terminates Agreement to Offer Test Kits	CI
2020	Applied BioSciences Begins Offering Coronavirus Test Kit to the General Public to Combat Spread of COVID-19	CI

Applied Biosciences Corp. Reports Earnings Results for the Third Quarter Ended December 31, 2018

February 13, 2019 at 09:02 pm

Applied Biosciences Corp. announced earnings results for the third quarter ended December 31, 2018. For the third quarter, the company announced operating loss was USD 1.384 million compared to USD 342,857 a year ago. Net loss was USD 1.891 million compared to USD 335,726 a year ago. Basic loss per share was USD 0.16 compared to USD 0.02 a year ago. For the nine months, operating loss was USD 2.236 million compared to USD 717,467 a year ago. Net loss was USD 2.397 million compared to USD 711,470 a year ago. Basic loss per share was USD 0.22 compared to USD 0.05 a year ago.

Latest news about Applied Biosciences Corp.

Applied BioSciences Corp. Terminates Agreement to Offer Test Kits	24/04/20	CI
Applied BioSciences Begins Offering Coronavirus Test Kit to the General Public to Combat Spread of COVID-19	31/03/20	CI
Applied Biosciences Corp. Announces Resignation of Raymond Urbanski as Chief Executive Officer and Director	19/03/20	CI
Applied Biosciences Corp. Reports Earnings Results for the Third Quarter Ended December 31, 2019	18/02/20	CI
Applied Biosciences Corp. Reports Earnings Results for the Second Quarter Ended September 30, 2019	14/11/19	CI
Pond Naturals Signs Agreement with Applied BioSciences to Sell its X10 Pet Supplement in the US alongside CBD-based Herbal Pet products	17/10/19	CI
Applied Biosciences Corp. Appoints Michael Beaubaire as Director	07/10/19	CI
Applied BioSciences Corp. Announces Resignation of John Brady as Director	16/09/19	CI
Applied Biosciences Corp. announced that it has received $0.25 million in funding from FirstFire Capital Management LLC	08/09/19	CI
Applied Biosciences Corp. announced that it expects to receive $0.5 million in funding from FirstFire Capital Management LLC	03/09/19	CI
Applied Biosciences Corp. Reports Earnings Results for the First Quarter Ended June 30, 2019	14/08/19	CI
Applied Biosciences Corp. Reports Earnings Results for the Full Year Ended March 31, 2019	01/07/19	CI
Applied Biosciences Corp. Auditor Raises 'Going Concern' Doubt	30/06/19	CI
Applied BioSciences Launches Champ Organics CBD Product Line	06/06/19	CI
Applied Biosciences Corp. Appoints Raymond Urbanski as Chief Executive Officer and Director	28/05/19	CI
Applied BioSciences Corp. Appoints Raymond W. Urbanski as Chief Executive Officer	07/05/19	CI
Applied Biosciences Corp. Appoints Scott Stevens as Director	19/04/19	CI
Applied BioSciences Announces Partnership with Boxing Heavyweight Champion Shannon Briggs	20/03/19	CI
Applied Biosciences Corp. Reports Revenue Results for the Third Quarter of 2019	18/03/19	CI
Applied Biosciences Corp. Reports Earnings Results for the Third Quarter Ended December 31, 2018	13/02/19	CI
Xiang-Qun Xie Joins Applied Biosciences Corp.'s Scientific Advisory Board	24/01/19	CI
Applied Biosciences Corp. acquired an unknown majority stake in Trace Analytics for $1.25 million.	08/01/19	CI
Applied Biosciences Corp. Enters Vape Inhaler Market	07/11/18	CI
Applied Biosciences Corp Expands Product Line and Launches Hemp-Derived CBD Product Pet Line Under the HerbalPet Brand	22/10/18	CI
Applied Biosciences Corp. announced that it expects to receive $1 million in funding from Triton Funds LLC	14/10/18	CI

Chart Applied Biosciences Corp.

Duration

Period

More charts

Company Profile

Applied BioSciences Corp. is a vertically integrated company that is focused on the development of science-driven cannabinoid therapeutics/biopharmaceuticals. The Company delivers cannabidiol (CBD) products as well as testing and analytics capabilities to its customers. It sells consumer products, including health and wellness creams, tinctures, edibles, confections, clothing, apparel, and other various branded products. Its various brands include Remedi, Remedi Plus, HerbalPet, Champ Organics and Equine Care. Its products are focused on the medical, bioceutical and pet health industries. The Company's subsidiaries include Applied Products LLC, Trace Analytics, Inc., and API Holdings, LLC, among others.

Sector

Biotechnology & Medical Research

More about the company

Sector Other Biotechnology & Medical Research

	1st Jan change	Capi.
APPLIED BIOSCIENCES CORP.	-.--%	4.28K
MODERNA, INC.	+67.53%	63.85B
IQVIA HOLDINGS INC.	-0.77%	41.83B
LONZA GROUP AG	+44.98%	40.65B
CELLTRION, INC.	-10.87%	27.12B
ICON PUBLIC LIMITED COMPANY	+13.30%	26.52B
ALNYLAM PHARMACEUTICALS, INC.	-22.79%	18.69B
BIO-TECHNE CORPORATION	+4.70%	12.73B
UNITED THERAPEUTICS CORPORATION	+24.10%	12.11B
MEDPACE HOLDINGS, INC.	+27.41%	12.07B

Other Biotechnology & Medical Research